CD1-MR1 2015* Regan Anderson
Victoria University of Wellington, WELLINGTON, New Zealand
Presentations this author is a contributor to:
Synthetic glycolipid-peptide conjugate vaccines utilise NKT cell help in vivo for improved CD8+ T cell immune responses (#52)
6:56 PM
Taryn Osmond
Rapid Fire Talks II
An NKT cell-activating glycolipid-peptide conjugate vaccine enhances human anti-viral CD8+ T cell responses (#84)
4:00 PM
Astrid Authier-Hall
Poster Listing